157 related articles for article (PubMed ID: 34055488)
1. Identification of KIF4A as a pan-cancer diagnostic and prognostic biomarker via bioinformatics analysis and validation in osteosarcoma cell lines.
Pan J; Lei X; Mao X
PeerJ; 2021; 9():e11455. PubMed ID: 34055488
[TBL] [Abstract][Full Text] [Related]
2. DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway.
Yang M; Zhang H; Gao S; Huang W
J Orthop Surg Res; 2023 Feb; 18(1):145. PubMed ID: 36849972
[TBL] [Abstract][Full Text] [Related]
3. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression.
Jin W; Ye L
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013367
[TBL] [Abstract][Full Text] [Related]
4. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer.
Hou PF; Jiang T; Chen F; Shi PC; Li HQ; Bai J; Song J
Cell Death Dis; 2018 May; 9(5):477. PubMed ID: 29706624
[TBL] [Abstract][Full Text] [Related]
5. An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
Xue D; Cheng P; Han M; Liu X; Xue L; Ye C; Wang K; Huang J
Onco Targets Ther; 2018; 11():4755-4768. PubMed ID: 30127624
[TBL] [Abstract][Full Text] [Related]
6. Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types.
Hou G; Dong C; Dong Z; Liu G; Xu H; Chen L; Liu L; Wang H; Zhou W
Sci Rep; 2017 Jun; 7(1):4148. PubMed ID: 28646197
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway.
Zhu D; Xu X; Zhang M; Wang T
Exp Ther Med; 2021 Nov; 22(5):1339. PubMed ID: 34630693
[TBL] [Abstract][Full Text] [Related]
8. Identification of KIF4A as a prognostic biomarker for esophageal squamous cell carcinoma.
Wang L; Liu G; Bolor-Erdene E; Li Q; Mei Y; Zhou L
Aging (Albany NY); 2021 Nov; 13(21):24050-24070. PubMed ID: 34775374
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic and Experimental Analyses Reveal That KIF4A Is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical Cancer Patients.
Wu J; Li L; Zhong H; Zhang HH; Li J; Zhang HB; Zhao YQ; Xu B; Song QB
Curr Med Sci; 2022 Dec; 42(6):1273-1284. PubMed ID: 36260268
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
[TBL] [Abstract][Full Text] [Related]
11. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
[TBL] [Abstract][Full Text] [Related]
12. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
Taniwaki M; Takano A; Ishikawa N; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6624-31. PubMed ID: 18006763
[TBL] [Abstract][Full Text] [Related]
13.
Yue C; Liang C; Li P; Yan L; Zhang D; Xu Y; Wei Z; Wu J
Onco Targets Ther; 2019; 12():11637-11650. PubMed ID: 32021243
[TBL] [Abstract][Full Text] [Related]
14. Increased KIF4A expression is a potential prognostic factor in prostate cancer.
Gao H; Chen X; Cai Q; Shang Z; Niu Y
Oncol Lett; 2018 May; 15(5):7941-7947. PubMed ID: 29725481
[TBL] [Abstract][Full Text] [Related]
15. miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2.
Liu C; Yi X
Diagn Pathol; 2020 Jul; 15(1):96. PubMed ID: 32709240
[TBL] [Abstract][Full Text] [Related]
16. Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma.
Kahm YJ; Kim IG; Jung U; Lee JH; Kim RK
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067227
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.
Han C; Wang W
Mol Med Rep; 2018 Mar; 17(3):4777-4784. PubMed ID: 29328417
[TBL] [Abstract][Full Text] [Related]
18. KIF4A drives gliomas growth by transcriptional repression of Rac1/Cdc42 to induce cytoskeletal remodeling in glioma cells.
Zhang H; Meng S; Chu K; Chu S; Fan YC; Bai J; Yu ZQ
J Cancer; 2022; 13(15):3640-3651. PubMed ID: 36606197
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
20. microRNA-524-5p inhibits proliferation and induces cell cycle arrest of osteosarcoma cells via targeting CDK6.
Chen H; Cheng C; Gao S
Biochem Biophys Res Commun; 2020 Sep; 530(3):566-573. PubMed ID: 32747087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]